E Van Cutsem Selected Research

E Van Cutsem Research Topics

Disease

54	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 03/2000
37	Neoplasms (Cancer) 12/2023 - 03/2000
14	Adenocarcinoma 01/2022 - 01/2004
12	Stomach Neoplasms (Stomach Cancer) 01/2021 - 07/2000
11	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2003
9	Colonic Neoplasms (Colon Cancer) 11/2023 - 03/2000
9	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 10/2001
7	Disease Progression 10/2022 - 11/2001
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2020 - 01/2009
6	Rectal Neoplasms (Rectal Cancer) 04/2015 - 03/2000
6	Carcinoma (Carcinomatosis) 01/2009 - 05/2002
4	Hand-Foot Syndrome 01/2023 - 03/2000
4	Neutropenia 01/2021 - 11/2001
3	Fatigue 12/2023 - 01/2018
3	Microsatellite Instability 10/2022 - 01/2019
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2011 - 07/2000
3	Esophageal Neoplasms (Esophageal Cancer) 06/2004 - 12/2000
2	Pain (Aches) 12/2023 - 01/2023
2	Esophageal Squamous Cell Carcinoma 12/2023 - 01/2022
2	Nausea 01/2021 - 04/2002
2	Neuroendocrine Carcinoma 10/2020 - 07/2016
2	Carcinoid Tumor (Carcinoid) 10/2020 - 01/2009
2	Diarrhea 04/2002 - 03/2000
2	Stomatitis 04/2002 - 11/2001
2	Alopecia (Baldness) 04/2002 - 11/2001
2	Fever (Fevers) 04/2002 - 11/2001
2	Sepsis (Septicemia) 04/2002 - 11/2001
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Liver Failure 10/2022
1	Anemia 01/2021
1	Vomiting 01/2021
1	Appendicitis 07/2020
1	Appendiceal Neoplasms (Appendix Cancer) 07/2020
1	Posterior Leukoencephalopathy Syndrome 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020

Drug/Important Bio-Agent (IBA)

18	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2000
16	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 01/2001
15	Capecitabine (Xeloda)FDA Link 01/2023 - 03/2000
13	Bevacizumab (Avastin)FDA Link 03/2024 - 10/2009
12	Cetuximab (Erbitux)FDA Link 01/2022 - 04/2007
11	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 04/2002
11	Gemcitabine FDA Link 01/2021 - 10/2001
11	Leucovorin (Folinic Acid)FDA Link 01/2018 - 03/2000
7	trifluridine tipiracil drug combinationIBA 03/2024 - 01/2020
7	ErbB Receptors (EGF Receptor)IBA 01/2020 - 09/2005
6	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2000
5	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2018
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 04/2016
5	RamucirumabIBA 01/2020 - 04/2016
5	Panitumumab (Vectibix)FDA Link 01/2020 - 12/2007
4	Monoclonal AntibodiesIBA 02/2024 - 03/2012
4	Sodium Glutamate (Accent)IBA 11/2023 - 05/2011
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2014 - 06/2007
3	thiamine triphosphorate (TTP)IBA 08/2009 - 03/2000
3	raltitrexed (D 1694)IBA 03/2005 - 04/2002
2	tislelizumabIBA 12/2023 - 01/2022
2	Docetaxel (Taxotere)FDA Link 12/2023 - 01/2015
2	taxaneIBA 01/2023 - 09/2006
2	Codon (Codons)IBA 01/2022 - 12/2014
2	encorafenibIBA 01/2022 - 12/2021
2	pembrolizumabIBA 01/2021 - 01/2021
2	B7-H1 AntigenIBA 01/2021 - 01/2021
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2020 - 01/2017
2	regorafenibIBA 01/2020 - 10/2015
2	PlatinumIBA 12/2019 - 04/2016
2	pasireotideIBA 11/2019 - 01/2017
2	Everolimus FDA Link 11/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 02/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 01/2017
2	nintedanibIBA 01/2018 - 10/2015
2	Sunitinib (Sutent)FDA Link 02/2017 - 10/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 10/2015
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017 - 03/2016
2	cabozantinibIBA 01/2017 - 10/2015
2	Methotrexate (Mexate)FDA LinkGeneric 02/2006 - 07/2000
2	BilirubinIBA 02/2005 - 10/2001
2	Glucose (Dextrose)FDA LinkGeneric 06/2004 - 12/2000
2	CarbamatesIBA 11/2001 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 07/2001 - 03/2000
1	Programmed Cell Death 1 ReceptorIBA 12/2023
1	atezolizumabIBA 10/2022
1	NivolumabIBA 10/2022
1	IpilimumabIBA 10/2022
1	binimetinibIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	ibrutinibIBA 01/2021
1	tipiracilIBA 01/2020
1	Trifluridine (Viroptic)FDA LinkGeneric 01/2020

Therapy/Procedure

44	Drug Therapy (Chemotherapy) 02/2024 - 03/2000
25	Therapeutics 02/2024 - 03/2000
7	Radiotherapy 01/2018 - 03/2000
4	Chemoradiotherapy 06/2008 - 03/2002
2	Aftercare (After-Treatment) 01/2018 - 10/2004
2	Precision Medicine 02/2015 - 09/2014
2	Palliative Care (Palliative Therapy) 10/2004 - 04/2004
1	Drug Tapering 01/2023
1	Immunotherapy 01/2022
1	Appendectomy 07/2020